Literature DB >> 15780685

A comparison of recovered bipolar patients, healthy relatives of bipolar probands, and normal controls using the short TEMPS-A.

Mauro V Mendlowicz1, Girardin Jean-Louis, John R Kelsoe, Hagop S Akiskal.   

Abstract

OBJECTIVE: To investigate the presence of temperament dysregulation in healthy relatives of bipolar probands (RBP), a population at high risk for developing mood disorders, by comparing them with clinically recovered bipolar patients (BP) and normal controls (NC).
METHOD: 52 RBP and 23 BP were originally recruited for a multicenter genetic study in bipolar disorders. NC (n=102) were also recruited by newspaper advertisement, radio and television announcements, flyers, newsletters, or word of mouth. All volunteers were asked to complete the TEMPS-A Scale, a self-report questionnaire designed to measure temperamental variations in psychiatric patients and healthy volunteers. In scoring temperaments, we relied upon the short validated version of the TEMPS-A [J. Affect. Disord. (2004)], from which traits with loadings <0.035 had been deleted.
RESULTS: To examine differences in temperament dimensions among the three groups, a MANCOVA model was constructed using diagnostic group as the fixed factor (BP vs. RBP vs. NC); effects of age and gender were adjusted as covariates. MANCOVA showed overall group effect on the dependent variables (Hotelling's F5,175=6.64, p<0.001). Four dependent variables (dysthymic, cyclothymic, irritable, and anxious temperaments) showed significant between-group differences. RBP showed lower cyclothymic temperament scores than BP, but higher scores than NC. BP and RBP showed higher anxious temperament scores than NC. Hyperthymic scores were significantly highest in the NC. LIMITATION: In view of the small cell sizes, bipolar I vs. bipolar II subanalyses could not be conducted.
CONCLUSIONS: Methodologic strengths of the present analyses is that the BP group had clinically recovered, and we used the validated short version of the TEMPS-A for the present analyses. Our findings suggest that some clinically healthy relatives of bipolar probands exhibit a subclinical cyclothymic instability in mood, interest, self-confidence, sleep, and/or energy as well as anxiety proneness that is not observed among normal controls. These traits may represent vulnerability markers and could presumably be used to identify individuals at high risk for developing bipolar spectrum disorders, or specific clinical subtypes (e.g., bipolar I, bipolar II) within this spectrum. This is a conceptual perspective with many unanswered questions. Resolution of these questions will require innovative definitions of phenotypes to be included in the analyses of the temperament subscales in different populations. The temperament subscales themselves need to be calibrated properly, to find out which traits or specific combinations of trains are most promising. More extensive and complex quantitative trait analyses of these temperaments in a much expanded sample are reported elsewhere in this issue [J. Affect. Disord. (2004)].

Entities:  

Mesh:

Year:  2005        PMID: 15780685     DOI: 10.1016/j.jad.2004.01.012

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  19 in total

1.  Dimensional endophenotypes in bipolar disorder: affective dysregulation and psychosis proneness.

Authors:  K Mahon; M M Perez-Rodriguez; N Gunawardane; K E Burdick
Journal:  J Affect Disord       Date:  2013-08-14       Impact factor: 4.839

2.  Affective temperaments and neurocognitive functioning in bipolar disorder.

Authors:  Manuela Russo; Katie Mahon; Megan Shanahan; Elizabeth Ramjas; Carly Solon; Raphael J Braga; Katherine E Burdick
Journal:  J Affect Disord       Date:  2014-08-05       Impact factor: 4.839

3.  Genome-wide association study of temperament in bipolar disorder reveals significant associations with three novel Loci.

Authors:  Tiffany A Greenwood; Hagop S Akiskal; Kareen K Akiskal; John R Kelsoe
Journal:  Biol Psychiatry       Date:  2012-02-23       Impact factor: 13.382

Review 4.  The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents.

Authors:  Marta Hauser; Christoph U Correll
Journal:  Can J Psychiatry       Date:  2013-01       Impact factor: 4.356

5.  Factor analysis of temperament and personality traits in bipolar patients: Correlates with comorbidity and disorder severity.

Authors:  Frank Qiu; Hagop S Akiskal; John R Kelsoe; Tiffany A Greenwood
Journal:  J Affect Disord       Date:  2016-10-02       Impact factor: 4.839

6.  Assessment Tools for Adult Bipolar Disorder.

Authors:  Christopher J Miller; Sheri L Johnson; Lori Eisner
Journal:  Clin Psychol (New York)       Date:  2009-06-01

7.  Affective Temperament Profiles in Patients with Multiple Sclerosis: Association with Mood Disorders.

Authors:  Adile Özkan; Kürşat Altinbaş; Emine Rabia Koç; Halil Murat Şen; Handan Işın Özişik Karaman
Journal:  Noro Psikiyatr Ars       Date:  2015-10-22       Impact factor: 1.339

Review 8.  The link between bipolar disorders and creativity: evidence from personality and temperament studies.

Authors:  Shefali Srivastava; Terence A Ketter
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

9.  Heritability and genome-wide SNP linkage analysis of temperament in bipolar disorder.

Authors:  Tiffany A Greenwood; Judith A Badner; William Byerley; Paul E Keck; Susan L McElroy; Ronald A Remick; A Dessa Sadovnick; Hagop S Akiskal; John R Kelsoe
Journal:  J Affect Disord       Date:  2013-06-10       Impact factor: 4.839

10.  Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents.

Authors:  Gonzalo Salazar de Pablo; Daniel Guinart; Barbara A Cornblatt; Andrea M Auther; Ricardo E Carrión; Maren Carbon; Sara Jiménez-Fernández; Ditte L Vernal; Susanne Walitza; Miriam Gerstenberg; Riccardo Saba; Nella Lo Cascio; Martina Brandizzi; Celso Arango; Carmen Moreno; Anna Van Meter; Christoph U Correll
Journal:  J Child Adolesc Psychopharmacol       Date:  2020-02-21       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.